To understand the range of governmental priorities for the bioeconomy, we spoke with key agencies represented on the National Bioeconomy Board to collect their perspectives.
Congress should foster a more responsive and evidence-based ecosystem for GenAI-powered educational tools, ensuring that they are equitable, effective, and safe for all students.
Without independent research, we do not know if the AI systems that are being deployed today are safe or if they pose widespread risks that have yet to be discovered, including risks to U.S. national security.
Companies that store children’s voice recordings and use them for profit-driven applications without parental consent pose serious privacy threats to children and families.
Privacy laws are only effective if they include civil rights protections that ensure personal data is processed safely and fairly regardless of race, gender, sexuality, age, or other protected characteristics.
What if the concurrent challenges of digital upskilling and teacher shortages could help solve one another?
Create a 10-year pilot AI Entrepreneur Visa program for a select group of countries to demonstrate the potential efficacy of the visa.
Urgent policy action is essential to address bias, promote diversity, increase transparency, and enforce accountability in clinical decision support AI systems.
Federal legislation would provide funding for grants and technical assistance to states and districts in planning and implementing comprehensive AI policy-to-practice plans.
Congress should assign and fund an agency office within the BIS to act as an information clearinghouse for receiving, triaging, and distributing reports on dual-use AI capabilities.
Congress should pass legislation to create a pilot program under the Department of Defense to expand access to shared commercial classified spaces and infrastructure.
Congress should establish a National Center for AI in Education to build the capacity of education agencies to undertake evidence-based continuous improvement in AI in education.